Navigation Links
Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
Date:3/23/2011

EAST NORRITON, Pa., March 23, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D. and Giuseppe Remuzzi, M.D., F.R.C.P., from the Harvard Stem Cell Institute and Mario Negri Institute respectively, to its panel of Research & Development Advisors. This panel provides counsel to Tengion and engages leading researchers, clinicians, and patient advocates with the company as it advances its Organ Regeneration Platform™. The newest additions to the panel will work with Tengion in the area of renal function and chronic kidney disease (CKD) as the Company continues to advance its Neo-Kidney Augment™ program. The Neo-Kidney Augment, which is designed to delay or prevent the need for dialysis or kidney transplantation in patients at risk of chronic kidney failure, has demonstrated consistently positive data that Tengion scientists have published or presented in four different animal models of kidney failure, including in large animals.  

"The appointment of these leaders to our advisory panel will provide Tengion with rich insights as we work to advance our Neo-Kidney Augment to clinical trials," said Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion. "There is a great need for new treatments for patients with chronic kidney disease," stated Dr. Remuzzi. "I look forward to helping Tengion identify the most rapid and efficient pathways to clinical trials." Dr. Humphreys added, "The recent preclinical findings for Tengion's Neo-Kidney Augment show that innovative approaches are beginning to offer promising results. I am enthusiastic about working with Tengion to explore these findings and further advance development."

Joining Tengion's panel of Research & Development Advisors are:

Giu
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
2. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
3. Tengion Announces Second Closing of Series C Financing
4. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
5. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
6. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
7. Tengion Appoints A. Brian Davis Chief Financial Officer
8. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
9. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
10. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
11. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015  EMD Serono today ... Darmstadt, Germany , appointed ... Head of Global Clinical Development.  Dr. Reicin brings ... experience in Oncology and Immunology. She is an ... served as a Vice President in various capacities ...
(Date:4/16/2015)... MENLO PARK, Calif. , April 16, 2015 /PRNewswire/ ... the Company), a biopharmaceutical company focused on developing and ... today announced that the Mayo Clinic Cancer Center ... for the ongoing, multicenter Phase I/II study of VAL-083 ... common and deadly form of human brain cancer. ...
(Date:4/16/2015)... 16, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... non-toxic DCVax® personalized immune therapies for cancer, announced ... Loncar Cancer Immunotherapy Index (LCINDX), a professional index ... immunotherapy field within the biotechnology space.  ... 25 companies" in the immunotherapy space, including 6 ...
(Date:4/16/2015)... 2015 Modality Solutions, a company ... highly regulated industries, is pleased to announce its ... columnist for Cold Chain IQ - Temperature Control ... column titled, Global Cold Chain Connections, is dedicated ... life sciences, pharmaceutical and healthcare supply chains. ...
Breaking Biology Technology:Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 2NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 3Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 2Modality Solutions Gary Hutchinson Named Columnist for Cold Chain IQ 3
... will receive the Johnson & Johnson Dr. Paul Janssen Award ... a series of events that celebrate his central role in ... signaling molecule of angiogenesis. His research has opened the door ... combat a serious eye disorder and contributed to the development ...
... 13Researchers at Vanderbilt University have developed a new technique that ... tissue at multiple points simultaneously, a method that could help ... and change shape. UV lasers are a commonly-used ... incisions by vaporizing one point at a time in a ...
... 2011 Saladax Biomedical, Inc., a privately held company ... promise of personalized medicine for new and existing therapeutics, ... of Saladax, will be presenting at the Annual UBS ... York in New York City on Tuesday, September 20, ...
Cached Biology Technology:Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 2Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 3Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 4Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 5Saladax Biomedical, Inc. to Present at the Annual UBS Global Life Sciences Conference in New York City 2
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... of poor rice farmers and consumers in Asia have received ... While the world's trading nations remain deadlocked on how to ... farmers of the developing world, research just published has confirmed ... planet's two most populous countries, China and India. , The ...
... damaged heart muscle tissue . . . regenerate injured bone ... . even reverse nerve damage. Human stem cells offer tremendous ... and a variety of other human health problems. , Up ... ethical controversy -- as well as by the rarity of ...
... emerged field of bacterial riboswitches may be a good ... to a report by Yale researchers in the journal ... control gene expression in essential metabolic pathways. Researchers in ... Henry Ford II Professor of Molecular, Cellular and ...
Cached Biology News:Some good news for the world's poor 2Some good news for the world's poor 3Some good news for the world's poor 4From one cell, many possible cures 2From one cell, many possible cures 3Switching to new anti-bacterial targets: Riboswitches 2
... Mouse Serum • Mouse serum is collected off the ... 8-12 weeks of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: